Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 225

1.

CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients.

Pieper J, Herrath J, Raghavan S, Muhammad K, Vollenhoven Rv, Malmström V.

BMC Immunol. 2013 Aug 5;14:34. doi: 10.1186/1471-2172-14-34.

2.

Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and -negative rheumatoid arthritis patients.

Gómez-Puerta JA, Celis R, Hernández MV, Ruiz-Esquide V, Ramírez J, Haro I, Cañete JD, Sanmartí R.

Arthritis Res Ther. 2013 Nov 7;15(6):R182. doi: 10.1186/ar4372.

3.

CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production.

Cutolo M, Soldano S, Montagna P, Sulli A, Seriolo B, Villaggio B, Triolo P, Clerico P, Felli L, Brizzolara R.

Arthritis Res Ther. 2009;11(6):R176. doi: 10.1186/ar2865. Epub 2009 Nov 23.

4.

CCR6(+) Th cell populations distinguish ACPA positive from ACPA negative rheumatoid arthritis.

Paulissen SM, van Hamburg JP, Davelaar N, Vroman H, Hazes JM, de Jong PH, Lubberts E.

Arthritis Res Ther. 2015 Nov 30;17:344. doi: 10.1186/s13075-015-0800-5.

5.

Weak CD4+ T-cell responses to citrullinated vimentin in rheumatoid arthritis patients carrying HLA-DR9 alleles.

Catalán D, Aravena O, Zúñiga R, Silva N, Escobar A, Sabugo F, Wurmann P, Soto L, González R, Alfaro J, Larrondo M, Cuchacovich M, Aguillón JC.

Rheumatol Int. 2012 Jun;32(6):1819-25. doi: 10.1007/s00296-011-2039-z. Epub 2011 Jul 19.

PMID:
21769486
6.

Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-α agents.

Picchianti Diamanti A, Rosado MM, Scarsella M, Germano V, Giorda E, Cascioli S, Laganà B, D'Amelio R, Carsetti R.

Clin Exp Immunol. 2014 Sep;177(3):630-40. doi: 10.1111/cei.12367.

7.

Abatacept reduces levels of switched memory B cells, autoantibodies, and immunoglobulins in patients with rheumatoid arthritis.

Scarsi M, Paolini L, Ricotta D, Pedrini A, Piantoni S, Caimi L, Tincani A, Airò P.

J Rheumatol. 2014 Apr;41(4):666-72. doi: 10.3899/jrheum.130905. Epub 2014 Mar 1.

PMID:
24584924
8.

Evidence for a functional role of IgE anticitrullinated protein antibodies in rheumatoid arthritis.

Schuerwegh AJ, Ioan-Facsinay A, Dorjée AL, Roos J, Bajema IM, van der Voort EI, Huizinga TW, Toes RE.

Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2586-91. doi: 10.1073/pnas.0913054107. Epub 2010 Jan 25. Retraction in: Schuerwegh AJ, Ioan-Facsinay A, Dorjee AL, Roos J, Bajema IM, van der Voort EI, Huizinga TW, Toes RE. Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20345.

9.

Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexate.

Hensvold AH, Joshua V, Li W, Larkin M, Qureshi F, Israelsson L, Padyukov L, Lundberg K, Defranoux N, Saevarsdottir S, Catrina AI.

Arthritis Res Ther. 2015 Sep 4;17:239. doi: 10.1186/s13075-015-0760-9.

10.

Alterations of the synovial T cell repertoire in anti-citrullinated protein antibody-positive rheumatoid arthritis.

Cantaert T, Brouard S, Thurlings RM, Pallier A, Salinas GF, Braud C, Klarenbeek PL, de Vries N, Zhang Y, Soulillou JP, Tak PP, Baeten D.

Arthritis Rheum. 2009 Jul;60(7):1944-56. doi: 10.1002/art.24635.

11.

Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept.

Fiocco U, Sfriso P, Oliviero F, Pagnin E, Scagliori E, Campana C, Dainese S, Cozzi L, Punzi L.

Autoimmun Rev. 2008 Oct;8(1):76-82. doi: 10.1016/j.autrev.2008.07.035. Epub 2008 Aug 15. Review.

PMID:
18718877
12.

Longterm effects of rituximab on B cell counts and autoantibody production in rheumatoid arthritis: use of high-sensitivity flow cytometry for more sensitive assessment of B cell depletion.

Váncsa A, Szabó Z, Szamosi S, Bodnár N, Végh E, Gergely L, Szucs G, Szántó S, Szekanecz Z.

J Rheumatol. 2013 May;40(5):565-71. doi: 10.3899/jrheum.111488. Epub 2013 Apr 1.

PMID:
23547216
13.

Production of autoantibodies against citrullinated antigens/peptides by human B cells.

Bellatin MF, Han M, Fallena M, Fan L, Xia D, Olsen N, Branch V, Karp D, Stastny P.

J Immunol. 2012 Apr 1;188(7):3542-50. doi: 10.4049/jimmunol.1100577. Epub 2012 Feb 15.

14.

Anti-inflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts in rheumatoid arthritis.

Blaschke S, Viereck V, Schwarz G, Klinger HM, Guerluek S, Müller GA.

Scand J Rheumatol. 2009;38(4):235-9. doi: 10.1080/03009740802572475.

PMID:
19247848
15.

[Is rheumatoid arthritis without anti-citrullinated peptide antibody a genetically distinct subset?].

Ohmura K.

Nihon Rinsho Meneki Gakkai Kaishi. 2009 Dec;32(6):484-91. Review. Japanese.

16.

CTLA-4IG suppresses reactive oxygen species by preventing synovial adherent cell-induced inactivation of Rap1, a Ras family GTPASE mediator of oxidative stress in rheumatoid arthritis T cells.

Remans PH, Wijbrandts CA, Sanders ME, Toes RE, Breedveld FC, Tak PP, van Laar JM, Reedquist KA.

Arthritis Rheum. 2006 Oct;54(10):3135-43.

17.
18.

Immunohistological analysis of synovium treated with abatacept in rheumatoid arthritis.

Kanbe K, Chiba J, Nakamura A.

Rheumatol Int. 2013 Jul;33(7):1883-7. doi: 10.1007/s00296-011-2326-8. Epub 2012 Jan 3.

PMID:
22212411
19.

Pathogenesis of rheumatoid arthritis.

Weyand CM, Goronzy JJ.

Med Clin North Am. 1997 Jan;81(1):29-55.

PMID:
9012754
20.

Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.

Yudoh K, Matsuno H, Nakazawa F, Yonezawa T, Kimura T.

Arthritis Rheum. 2000 Mar;43(3):617-27.

Supplemental Content

Support Center